Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study Comparing Metabolic Response Evaluation by F-18 FDG PET-CT Versus Conventional Imaging for Outcome Stratification in Patients With Advanced Breast Cancer Receiving First-line Systemic Therapy

NCT07173868 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07173868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study Comparing Metabolic Response Evaluation by F-18 FDG PET-CT Versus Conventional Imaging for Outcome Stratification in Patients With Advanced Breast Cancer Receiving First-line Systemic Therapy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
July 25, 2025
Completion date
December 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histologically confirmed metastatic or locally advanced breast cancer with no radical topical treatment available, if there is liver metastasis, which the researcher believes will be difficult to evaluate the response accurately with bone metastasis or ct